This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_BLADDER_EXALLC for full statistics.
Carcinoma in situ, bladder
CD2_INSITU_BLADDER
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
517355 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1071 |
4. Check minimum number of eventsNone |
1071 |
5. Include endpointsNone |
1071 |
6. Filter based on genotype QC (FinnGen only) |
1071 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D09
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ, bladder
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ, bladder
- Carcinoma in situ of other and unspecified sites
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1071 | 200 | 871 |
| Unadjusted period prevalence (%) | 0.33 | 0.07 | 0.38 |
| Median age at first event (years) | 71.53 | 68.62 | 72.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 990
- Matched controls
- 9898
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
77.4
323.0
406
88
UKC02
NOMESCO Finland
Cystoscopy
277.0
323.0
971
1533
KCD02
NOMESCO Finland
Transurethral resection of bladder
126.9
323.0
660
153
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
135.3
323.0
634
128
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
139.2
323.0
493
70
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
9553.9
323.0
711
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
131.3
323.0
577
104
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
66.7
259.7
297
63
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
70.2
252.0
286
57
R31
ICD-10 Finland
Unspecified haematuria
12.1
247.7
551
927
ZX136
NOMESCO Finland
Intravesicalis
61.8
149.7
174
34
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
+∞
138.9
130
*
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
40.4
129.0
163
48
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
27.2
106.7
149
64
WX320
NOMESCO Finland
Spinalanesthesy
4.6
99.6
464
1590
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
+∞
82.5
78
*
XKD00
NOMESCO Finland
Uroflowmetry
3.5
68.5
446
1881
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.6
63.2
371
1421
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.9
63.0
192
385
U06
ICPC
Haematuria
9.2
55.6
121
147
TKC20
NOMESCO Finland
Catheterisation of bladder
4.7
54.6
207
525
KCW96
NOMESCO Finland
Other operations on bladder
26.9
54.2
75
30
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
19.1
52.4
81
46
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
51.7
411
1898
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
38.5
51.3
65
18
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
17.5
50.9
81
50
WX224
NOMESCO Finland
Blockade of obturius nerve
156.9
43.1
45
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
82.2
42.2
47
6
UKB02
NOMESCO Finland
Retrograde ureteroscopy
15.1
38.2
64
45
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.4
37.8
206
703
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
34.4
35.6
46
14
N30.0
ICD-10 Finland
Acute cystitis
3.6
34.2
169
531
KH1AD
NOMESCO Finland
CT of urinary organs
6.1
34.1
97
173
WX402
NOMESCO Finland
General anaesthesia
2.9
32.6
225
899
4CX01
NOMESCO Finland
NA
74.4
32.1
36
5
J01MA02
ATC
ciprofloxacin; systemic
2.2
31.9
505
3144
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
117.2
31.9
34
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
7.2
28.6
71
105
ZXC20
NOMESCO Finland
Use of chemical agents
6.5
27.9
75
124
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
27.5
247
1142
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
7.7
23.5
55
75
C66
ICD-10 Finland
Malignant neoplasm of ureter
37.3
23.1
29
8
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
23.0
22
*
KED22
NOMESCO Finland
Transurethral resection of prostate
2.8
22.8
161
640
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
7.2
22.8
56
82
ZXC15
NOMESCO Finland
Use of photodynamic technique
8.2
22.7
51
65
R33
ICD-10 Finland
Retention of urine
2.7
22.3
173
725
A98
ICPC
Health maint/preventive medicine
3.1
22.2
926
8156
U76
ICPC
Malignant neoplasm of bladder
35.9
22.1
28
8
G04BD12
ATC
mirabegron; oral
2.7
21.9
168
700
KCB00
NOMESCO Finland
Biopsy of bladder
20.6
21.8
32
16
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
21.4
187
839
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
12.3
21.2
38
32
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
42.6
20.5
25
6
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
13.5
19.8
34
26
KCC10
NOMESCO Finland
Cystoprostatectomy
12.1
18.9
34
29
G04CA02
ATC
tamsulosin; oral
1.8
18.4
444
3028
KDV10
NOMESCO Finland
Internal urethrotomy
6.1
17.9
49
84
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
12.8
17.7
31
25
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
13.4
17.5
30
23
N02BE01
ATC
paracetamol; systemic, rectal
2.1
17.5
846
7269
KH1DD
NOMESCO Finland
CT urography of urinary organs
29.4
17.5
23
8
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.7
17.4
50
91
JN4AD
NOMESCO Finland
Body CT examination
2.7
17.3
127
513
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
16.7
16
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
40.8
16.4
20
5
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
7.2
16.2
39
56
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
17.1
16.1
25
15
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.7
16.0
54
119
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
81.3
14.6
16
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
14.3
106
430
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
22.6
14.2
20
9
J01MA12
ATC
levofloxacin; systemic
1.9
13.7
234
1386
J01EA01
ATC
trimethoprim; systemic
1.9
13.4
209
1197
WZC30
NOMESCO Finland
Teaching
2.1
13.2
157
803
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
13.1
317
2102
KBH20
NOMESCO Finland
Replantation of ureter
50.7
12.9
15
*
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
12.5
12
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
6.4
12.5
32
51
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
12.5
490
3714
SPAT1263
SPAT
Sampling
1.7
12.4
413
2992
B02AA02
ATC
tranexamic acid; systemic
2.5
12.4
103
445
J01DB01
ATC
cefalexin; oral
1.7
12.4
761
6510
SPAT1167
SPAT
Insertion of urinary catheter
3.0
11.7
68
238
KBV10
NOMESCO Finland
Removal of stent from ureter
9.8
11.3
22
23
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.3
11.0
40
96
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
4.6
10.7
36
80
KC1GB
NOMESCO Finland
Cystography with X-ray
5.4
10.6
31
59
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
111.1
10.4
11
*
N30.9
ICD-10 Finland
Cystitis, unspecified
3.0
10.4
59
203
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
32.9
10.3
13
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
23.6
10.3
14
6
SPAT1312
SPAT
General health counselling
1.6
9.9
293
2028
U29
ICPC
Urinary symptom/complaint other
3.7
9.8
42
118
U07
ICPC
Urine symptom/complaint other
2.5
9.5
74
309
KCD30
NOMESCO Finland
Destruction of tumour of bladder
17.7
9.4
14
8
KBD00
NOMESCO Finland
Partial excision of ureter
30.3
9.4
12
*
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
3.5
9.2
41
120
G04CA01
ATC
alfuzosin; oral
1.7
9.1
207
1327
KA3EB
NOMESCO Finland
Antegrade pyelography
10.1
9.0
17
17
WX110
NOMESCO Finland
Local anesthesy
1.5
9.0
578
4771
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
8.8
420
3240
S18
ICPC
Laceration/cut
1.5
8.7
416
3212
R39.1
ICD-10 Finland
Other difficulties with micturition
2.9
8.7
52
188
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
8.3
8.6
18
22
JN4CD
NOMESCO Finland
Very extensive body CT
2.5
8.3
61
249
KDE20
NOMESCO Finland
Removal of foreign body from urethra
5.2
8.2
24
47
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
8.1
73
328
U05
ICPC
Urination problems other
2.4
8.1
68
297
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
11.8
8.1
14
12
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
17.3
8.1
12
7
SPAT1262
SPAT
Handing over of treatment supplies
1.6
8.1
221
1486
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.9
7.9
47
169
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.7
7.8
155
951
KGH10
NOMESCO Finland
Operation for phimosis
3.0
7.8
42
143
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
7.7
311
2298
WX702
NOMESCO Finland
Supraglottic ventilation device
2.7
7.6
50
192
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
7.6
128
746
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
7.6
372
2862
U01
ICPC
Dysuria/painful urination
2.5
7.5
55
224
SPAT1301
SPAT
No procedures
1.5
7.4
298
2198
U02
ICPC
Urinary frequency/urgency
1.9
7.3
102
556
RD211
NOMESCO Finland
NA
2.8
7.2
46
172
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
7.4
7.2
16
22
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
30.2
7.2
9
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
7.2
54
225
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
10.1
7.0
13
13
G04BD08
ATC
solifenacin; oral
2.0
6.9
83
426
KBV00
NOMESCO Finland
Insertion of stent into ureter
6.8
6.8
16
24
A02BC02
ATC
pantoprazole; systemic
1.4
6.8
603
5164
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.6
6.8
165
1071
JN4BD
NOMESCO Finland
Extensive body CT
1.7
6.8
136
839
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
6.5
78
402
KAC20
NOMESCO Finland
Nephroureterectomy
14.4
6.4
10
7
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.3
433
3519
KA1FN
NOMESCO Finland
Isotope renography
6.0
6.3
16
27
SPAT1153
SPAT
Removal of sutures
1.4
6.3
320
2459
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
6.3
6
*
B01AB05
ATC
enoxaparin; parenteral
1.5
6.2
290
2194
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.6
6.1
179
1220
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.1
327
2534
R30.0
ICD-10 Finland
Dysuria
2.8
6.1
36
131
N30
ICD-10 Finland
Cystitis
2.6
6.1
43
173
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
6.0
105
620
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
6.0
271
2031
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
861
3695
7.78
188.89
10.1
3.4
—
—
—
0
0
602
2157
5.09
154.45
6.7
2.6
3.5
3.5
e6/l
0.01
562
1907
691
3088
4.49
124.70
11.4
3.5
531.6
101.9
e6/l
1.66
636
2468
637
2802
4.14
114.63
10.6
3.4
0.2
0.5
e6/l
7.94
561
2184
985
6002
8.98
114.22
14.8
4.6
55.8
1182.2
e6/l
0.98
24
112
710
3426
4.18
110.33
12.4
3.9
161.0
119.8
e6/l
0.45
660
2599
741
4347
3.29
71.58
5.9
4.5
—
—
—
0
0
416
1766
3.22
71.03
9.7
3.0
1.0
1.0
e6/l
0.05
347
1084
393
1679
3.12
65.46
10.7
3.2
1.1
1.1
e6/l
0.02
324
1004
695
4228
2.83
57.22
8.2
5.0
0.0
0.0
estimate
0.00
190
823
696
4261
2.81
56.17
6.4
3.8
0.0
0.0
estimate
0.00
191
814
699
4304
2.80
55.50
6.4
3.8
0.0
0.0
estimate
0.00
182
784
813
5723
2.75
44.29
5.9
5.3
6.9
6.9
mmol/l
0.27
789
5409
175
604
3.27
40.05
8.4
2.8
0.2
0.3
e6/l
1.74
175
596
1007
8482
4.13
30.62
23.9
18.2
31.7
28.8
mg/l
1.59
878
6957
967
8038
3.09
28.22
26.0
17.1
70.8
73.9
ml/min/173m2
4.59
885
6704
1038
9023
5.88
28.15
29.9
21.7
139.5
139.6
mmol/l
0.66
1022
8789
1038
9039
5.81
27.72
30.2
21.9
4.0
4.0
mmol/l
0.69
1021
8800
500
3295
1.97
25.51
7.2
4.1
—
—
—
0
0
1043
9219
6.02
24.97
36.7
26.5
237.4
232.1
e9/l
1.88
1019
8938
1043
9220
6.02
24.95
36.8
26.5
4.4
4.4
e12/l
1.23
1017
8903
1043
9222
6.01
24.89
37.0
26.7
132.7
135.1
g/l
4.68
1030
9047
869
7023
2.26
24.12
9.3
8.2
78.7
80.8
u/l
0.81
824
6594
659
4937
1.87
21.15
7.3
6.8
10.7
12.7
umol/l
8.85
632
4705
752
5883
1.93
21.03
5.9
5.5
2.7
3.3
ug/l
0.94
673
5228
373
2365
1.89
20.17
3.3
2.7
—
—
—
0
0
378
2415
1.87
19.91
7.3
4.1
0.0
0.0
estimate
0.50
171
761
1013
8988
3.35
19.63
12.9
11.7
25.3
26.2
u/l
1.11
973
8616
786
6417
1.85
17.07
4.3
4.2
16.1
13.9
mm/h
2.53
699
5844
636
4884
1.74
17.04
8.0
7.5
1.2
1.2
mmol/l
0.75
528
4108
201
1110
2.00
15.93
5.0
3.8
—
—
—
0
0
566
4274
1.69
15.53
6.1
5.2
34.2
34.5
g/l
0.73
527
3967
854
7233
1.89
15.52
25.6
19.7
39.3
39.1
%
0.18
489
4434
531
3943
1.69
15.52
2.5
2.2
—
—
—
0
0
644
5073
1.68
14.68
9.6
9.2
4.6
4.4
e9/l
1.67
556
4416
581
4477
1.65
14.26
7.2
6.5
1.2
1.2
mmol/l
0.76
519
4042
240
1466
1.82
13.82
7.7
7.0
105.2
104.2
mmol/l
2.82
235
1427
946
8393
2.09
13.63
5.7
5.2
6.3
6.2
mmol/l
1.83
816
7499
407
2931
1.63
12.63
3.2
2.6
55.5
57.6
u/l
0.67
381
2711
280
1848
1.70
12.12
2.0
1.9
—
—
—
0
0
144
775
1.99
12.11
4.6
3.8
5.1
5.1
kpa
0.27
136
712
137
728
2.01
11.93
4.4
3.8
1.0
1.9
mmol/l
2.30
108
539
864
7535
1.76
11.84
4.7
4.3
2.0
2.1
mu/l
0.94
735
6701
788
6731
1.65
11.39
31.3
22.1
14.0
13.9
%
1.31
774
6581
132
721
1.95
10.60
1.9
1.7
—
—
—
0
0
423
3208
1.53
9.85
3.3
3.3
7.5
7.8
mmol/l
1.09
331
2647
924
8332
1.79
9.83
5.1
4.9
4.2
4.3
mmol/l
2.00
799
7581
360
2646
1.54
9.64
2.6
2.2
3.1
3.1
mg/l
0.11
305
2248
941
8550
1.83
9.50
5.7
5.5
2.4
2.5
mmol/l
2.55
813
7716
435
3355
1.50
9.17
4.3
4.1
11.0
9.6
mg/mmol
0.21
298
2230
581
4765
1.48
8.93
5.2
4.7
20.7
21.7
%
0.85
330
2547
911
8241
1.71
8.82
5.0
4.8
1.3
1.4
mmol/l
3.40
782
7419
902
8173
1.66
8.25
7.7
6.7
42.1
41.1
mmol/mol
2.32
805
7447
178
1149
1.66
8.09
3.7
4.3
24.7
28.1
ug/l
0.07
148
980
694
5966
1.46
7.90
3.9
3.4
15.0
15.0
pmol/l
0.07
580
5257
883
7988
1.60
7.80
4.5
4.3
1.4
1.3
mmol/l
3.23
749
7145
14
25
5.66
7.55
2.2
2.1
2.2
9.6
nmol/l
0.44
14
20
28
89
3.20
7.30
1.5
1.3
—
—
—
0
0
81
431
1.95
7.02
2.2
1.8
—
—
—
0
0
424
3380
1.42
6.99
3.5
3.3
0.7
0.8
ug/l
0.41
323
2438
604
5149
1.40
6.61
3.2
3.4
56.1
60.6
u/l
0.49
550
4719
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
81
446
1.88
6.36
4.4
2.6
0.3
0.4
u/ml
0.46
47
249
331
2559
1.42
6.35
1.6
1.6
19.1
19.4
nmol/l
0.15
270
2180
218
1559
1.50
6.27
3.1
2.7
2.3
2.2
g/l
1.26
195
1448
56
272
2.12
6.25
1.5
1.5
—
—
—
0
0
393
3148
1.39
6.09
4.1
3.4
2.3
2.3
mmol/l
0.19
328
2694
209
1493
1.50
6.02
3.2
2.7
18.8
22.8
%
4.18
175
1281
184
1284
1.52
5.92
1.8
1.8
—
—
—
0
0
416
3377
1.38
5.90
3.4
3.3
2518.2
1844.9
ng/l
0.89
367
2993
80
450
1.84
5.89
3.5
2.7
—
—
—
0
0
497
4159
1.36
5.80
2.2
2.1
91.9
91.7
pmol/l
0.05
278
2321
82
472
1.80
5.61
2.3
2.0
—
—
—
0
0
125
808
1.62
5.60
4.3
4.2
1.2
1.2
mmol/l
1.22
105
709
62
327
1.95
5.56
3.4
3.2
23.9
24.9
mmol/l
1.10
54
278
407
3317
1.37
5.55
2.1
2.1
79.5
77.4
nmol/l
0.61
335
2879
217
1588
1.46
5.51
31.8
29.5
1.4
1.5
inr
0.55
39
217
425
3492
1.36
5.49
3.4
2.9
159.3
179.5
ug/l
0.90
373
3173
116
742
1.63
5.43
8.4
9.1
1.2
1.3
%
0.63
116
736
104
647
1.67
5.42
1.6
1.5
—
—
—
0
0
180
1273
1.50
5.42
1.8
1.9
—
—
—
0
0
155
1063
1.54
5.39
4.2
3.9
1.2
2.0
mmol/l
1.96
118
852
115
736
1.63
5.37
8.6
9.2
0.5
0.7
%
3.38
115
730
155
1070
1.52
5.23
6.8
7.5
10.6
11.2
mmol/l
0.47
146
1012
472
3977
1.33
5.03
5.4
4.2
44.4
68.7
ng/l
1.08
403
3147
56
296
1.94
5.01
2.2
2.4
203.1
115.3
ug/min
0.29
32
177
35
156
2.29
4.86
1.3
1.3
8.9
7.6
u/l
0.32
28
121
224
1688
1.41
4.80
3.2
2.7
11.1
12.4
umol/l
1.74
205
1568
23
84
2.78
4.80
1.1
1.3
—
—
—
0
0
141
974
1.52
4.74
1.9
2.3
0.2
0.2
g/l
0.93
130
899
57
313
1.87
4.58
1.6
1.7
—
—
—
0
0
193
1433
1.42
4.48
6.5
6.2
1.0
1.0
mmol/l
0.03
181
1325
47
244
1.97
4.46
1.8
2.4
124.9
128.8
g/l
0.36
34
183
82
509
1.66
4.34
4.7
4.2
23.5
24.1
mmol/l
0.88
70
461
326
2650
1.33
4.30
3.1
3.1
7148.8
7101.4
umol/l
0.00
257
2253
46
244
1.92
4.12
2.3
2.7
15.6
15.7
%
0.07
25
128
233
1811
1.37
4.11
1.7
1.7
1.6
1.5
mg/l
0.19
180
1429
186
1409
1.39
3.83
2.8
2.6
1.8
1.8
%
0.28
166
1252
180
1359
1.39
3.78
7.3
7.4
5.0
5.1
kpa
0.58
174
1289
180
1360
1.39
3.76
7.3
7.4
0.2
1.1
mmol/l
2.65
145
1042
180
1360
1.39
3.76
7.2
7.4
12.0
11.8
kpa
0.21
173
1293
361
3027
1.29
3.70
2.5
2.2
211.5
256.1
u/l
0.35
331
2819
254
2040
1.32
3.56
4.4
4.1
500.7
373.5
ng/l
0.21
218
1773
215
1689
1.34
3.51
4.0
3.4
0.8
0.8
mmol/l
0.02
200
1582
239
1921
1.31
3.32
8.1
4.1
1.0
1.0
kg/l
0.06
35
288
108
762
1.46
3.30
3.6
2.3
350.4
369.2
nmol/l
0.36
102
696
22
97
2.29
3.21
1.3
1.4
—
—
—
0
0
172
1334
1.34
3.05
3.2
4.3
222.7
254.0
u/l
3.42
162
1256
116
844
1.42
3.02
2.6
2.4
32.2
36.6
u/l
0.66
103
719
34
184
1.88
2.94
1.8
2.0
1.6
1.7
mmol/l
0.51
34
179
142
1087
1.35
2.74
2.7
2.9
9.0
10.6
umol/l
0.24
129
976
28
148
1.92
2.62
2.0
1.9
88.8
89.1
%
0.10
28
148
267
2239
1.26
2.61
1.8
1.8
431.2
10217806.5
pmol/l
1.00
201
1840
106
782
1.39
2.58
3.4
3.2
55.8
61.0
ml/min/173m2
0.72
45
333
15
62
2.44
2.54
1.1
1.2
25.1
19.3
iu/l
—
10
55
6
12
5.02
2.40
1.3
1.1
—
—
—
0
0
77
546
1.44
2.35
2.0
1.9
1.2
2.7
ug/l
0.80
68
485
60
406
1.51
2.32
4.4
3.7
80.1
10090.6
u/ml
0.84
52
345
322
2792
1.22
2.28
3.0
3.4
46.5
35.5
u/l
0.50
295
2652
23
122
1.90
2.17
1.5
1.7
321.1
289.7
mu/l
0.12
23
114
223
1872
1.24
2.14
4.1
3.2
2.5
2.5
mmol/l
0.87
198
1635
12
49
2.47
2.11
1.2
1.8
—
—
—
0
0
12
49
2.47
2.11
1.2
1.8
—
—
—
0
0
251
2141
1.23
2.07
1.9
1.8
1120.5
1141.9
nmol/l
0.13
173
1625
22
117
1.90
2.07
1.7
1.6
—
—
—
0
0
53
360
1.50
2.04
2.8
3.5
4.3
4.3
pmol/l
0.11
48
310
151
1226
1.27
1.94
5.0
4.9
32.8
32.3
%
0.27
92
817
37
237
1.58
1.86
1.3
1.3
—
—
—
0
0
37
237
1.58
1.86
1.3
1.3
—
—
—
0
0
8
28
2.87
1.86
1.1
1.5
—
—
—
0
0
79
590
1.37
1.84
1.6
1.9
1.7
1.5
g/l
1.13
71
507
268
2335
1.20
1.77
1.6
1.6
1.4
1.3
mmol/l
0.89
204
1909
131
1062
1.27
1.72
2.8
2.5
6.5
7.3
ug/l
0.24
115
947
0
48
0.00
1.70
0.0
1.0
—
—
—
0
0
33
211
1.58
1.69
1.2
1.3
—
—
—
0
0
18
98
1.85
1.62
1.4
2.4
852.9
646.3
ml
—
7
61
8
32
2.51
1.60
5.4
2.9
—
—
—
0
0
37
247
1.52
1.59
2.1
3.6
455.2
1348.2
u/ml
0.39
32
232
16
85
1.90
1.55
1.3
1.6
—
—
—
0
0
13
64
2.04
1.54
1.2
1.4
—
—
—
0
0
13
64
2.04
1.54
1.2
1.6
—
—
—
0
0
95
755
1.28
1.48
1.6
1.7
—
—
—
0
0
21
124
1.71
1.48
1.5
1.5
61.8
65.4
%
0.14
13
83
30
195
1.55
1.47
3.9
4.2
0.8
1.4
%
0.85
20
153
10
47
2.14
1.34
3.8
3.1
255.9
217.6
u/l
—
10
47
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
27
178
1.53
1.27
1.6
1.5
—
—
—
0
0
9
44
2.05
1.27
1.0
1.0
—
—
—
0
0
20
123
1.64
1.24
4.8
2.8
—
—
—
0
0
6
25
2.41
1.24
1.5
1.3
—
—
—
0
0
34
237
1.45
1.24
2.4
2.5
219.8
206.3
%
0.36
34
223
25
163
1.55
1.24
1.4
1.5
17366.8
68273.5
e6/l
1.19
15
98
23
147
1.58
1.23
1.6
1.5
—
—
—
0
0
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
26
172
1.52
1.21
1.1
1.1
—
—
—
0
0
22
141
1.57
1.18
5.4
6.8
7.7
7.2
mmol/l
0.31
17
117
20
126
1.60
1.15
1.2
1.1
1.0
32.5
iu/ml
—
5
27
37
268
1.39
1.12
3.8
3.5
1.7
1.6
mmol/l
0.46
37
262
111
932
1.21
1.11
2.2
2.2
10.1
12.6
nmol/l
2.96
96
803
38
277
1.39
1.11
1.3
1.4
—
—
—
0
0
17
104
1.64
1.09
1.2
1.3
12.9
13.2
u/l
0.03
17
99
11
193
0.57
1.08
1.1
1.2
—
5.2
—
0
16
32
229
1.41
1.04
1.5
1.6
—
—
—
0
0
15
91
1.66
1.01
2.3
1.7
—
—
—
0
0
20
131
1.54
1.00
3.2
4.3
63.0
55.9
%
—
10
86
9
49
1.84
0.98
5.9
4.2
78.4
97.8
nmol/l
—
9
49
45
349
1.30
0.91
1.3
1.4
—
—
—
0
0
14
86
1.64
0.91
2.3
1.9
1.1
1.8
u/field
—
8
29
34
253
1.36
0.91
4.1
3.6
7.8
7.7
mmol/l
0.07
34
248
16
102
1.58
0.90
1.3
1.4
15.6
13.7
u/l
0.22
16
97
8
42
1.91
0.88
2.4
1.3
—
—
—
0
0
34
256
1.34
0.85
1.5
1.5
—
—
—
0
0
8
45
1.78
0.84
1.5
1.3
—
—
—
0
0
31
232
1.35
0.82
1.5
1.4
—
—
—
0
0
18
259
0.69
0.80
1.3
3.1
24.4
34.1
umol/l
3.19
12
211
10
164
0.61
0.80
1.1
1.1
—
1.8
—
0
8
30
225
1.34
0.78
5.8
4.0
30.2
30.4
mg/l
0.01
19
146
21
150
1.41
0.73
1.7
1.6
—
—
—
0
0
7
39
1.80
0.72
2.0
3.0
—
—
—
0
0
7
39
1.80
0.72
2.0
3.0
—
—
—
0
0
53
435
1.23
0.72
4.0
3.8
1.3
1.4
mmol/l
0.18
53
428
33
256
1.30
0.71
1.7
1.7
13948.3
16127.2
e6/l
0.19
23
188
87
753
1.17
0.68
7.3
6.9
24.2
24.4
mmol/l
0.14
82
695
5
28
1.79
0.66
4.6
6.0
13.4
13.3
%
—
5
28
24
180
1.34
0.65
1.5
1.5
1428.4
1623.2
e6/l
0.13
18
127
5
29
1.73
0.64
1.0
1.1
—
24.8
u/ml
—
0
5
88
768
1.16
0.63
1.2
1.3
—
—
—
0
0
64
544
1.19
0.63
4.7
4.1
48.5
47.5
%
0.13
64
537
12
176
0.68
0.62
1.2
1.1
—
—
—
0
0
8
49
1.64
0.62
1.0
1.3
—
—
—
0
0
14
96
1.46
0.61
2.4
1.2
—
—
u/ml
—
0
0
39
317
1.24
0.60
1.2
1.6
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
26
201
1.30
0.59
1.1
1.3
—
—
—
0
0
10
64
1.57
0.58
1.0
1.2
—
—
—
0
0
19
140
1.36
0.58
1.2
1.6
—
—
—
0
0
40
328
1.23
0.58
1.1
1.2
158.4
150.8
iu/ml
—
9
112
14
196
0.71
0.57
1.4
1.2
4.1
4.0
mmol/l
0.13
14
178
8
54
1.49
0.57
2.8
1.9
—
—
—
0
0
14
195
0.71
0.56
1.9
1.3
1310.7
813.0
e6/l
—
9
160
14
195
0.71
0.56
1.8
1.3
18.9
49.5
e6/l
—
9
157
17
229
0.74
0.56
1.3
1.2
791.3
549.3
mg/l
0.56
17
210
31
248
1.26
0.55
1.7
1.8
—
—
—
0
0
22
168
1.32
0.55
4.5
2.9
23.8
61.7
u/ml
0.87
22
162
9
61
1.48
0.53
3.3
3.6
—
—
—
0
0
6
40
1.50
0.51
1.2
1.3
35.3
26.0
%
—
6
27
12
84
1.43
0.49
1.3
1.2
1.2
1.5
nmol/l
0.66
12
75
10
144
0.69
0.49
1.1
1.1
1.3
1.6
g/l
—
10
133
32
262
1.23
0.49
1.4
1.5
238.6
259.9
ug/g
0.25
17
165
7
111
0.63
0.48
1.7
2.0
—
—
—
0
0
133
1222
1.10
0.46
8.0
8.4
—
—
—
0
0
7
49
1.43
0.46
1.0
1.0
—
—
—
0
0
23
183
1.26
0.45
1.9
1.8
—
—
—
0
0
47
405
1.17
0.44
4.2
3.7
89.7
89.6
mg/l
0.00
34
336
47
405
1.17
0.44
4.2
3.7
50.4
75.6
mg/l
0.82
34
333
18
139
1.30
0.44
1.6
1.5
7.3
6.6
mmol/l
0.59
18
131
46
396
1.17
0.43
4.3
3.7
1.1
2.0
ratio
—
6
33
8
56
1.43
0.42
1.0
1.2
—
7.0
nmol/l
—
0
11
8
58
1.38
0.41
1.8
2.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
82
740
1.12
0.40
4.7
4.1
112.1
101.8
ng/l
0.36
66
641
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
30
251
1.20
0.39
1.6
1.5
1.4
25.4
iu/ml
—
9
53
20
160
1.25
0.38
1.3
1.5
—
—
—
0
0
31
261
1.19
0.38
1.8
1.7
—
—
—
0
0
25
206
1.22
0.38
1.2
1.2
49.8
56.1
u/l
0.08
25
181
16
203
0.78
0.38
1.4
1.6
—
—
—
0
0
8
115
0.69
0.37
1.8
2.0
—
—
—
0
0
11
81
1.36
0.36
1.0
1.0
—
—
—
0
0
9
71
1.27
0.36
1.0
1.5
—
241.4
—
0
7
12
156
0.77
0.34
1.2
1.1
—
—
—
0
0
31
361
0.85
0.34
2.0
1.8
—
—
—
0
0
22
264
0.83
0.33
1.1
1.0
—
—
—
0
0
18
147
1.23
0.31
1.7
2.6
13.2
20.0
mg/l
—
5
35
19
229
0.83
0.30
1.1
1.2
—
—
—
0
0
37
325
1.14
0.30
1.2
1.3
—
—
—
0
0
9
118
0.76
0.27
2.7
2.5
—
—
—
0
0
16
131
1.22
0.27
2.4
4.2
—
—
—
0
0
20
234
0.85
0.25
1.8
1.6
—
—
—
0
0
20
232
0.86
0.23
1.1
1.2
—
—
—
0
0
7
91
0.77
0.22
1.0
1.0
—
—
—
0
0
45
410
1.10
0.22
3.5
2.7
3.2
3.1
g/l
0.02
31
323
0
11
0.00
0.21
0.0
5.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
3.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
5
43
1.16
0.21
1.0
1.7
620.6
1486.7
u/ml
—
5
43
42
383
1.10
0.21
4.3
2.9
1.4
1.5
g/l
0.11
30
335
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
40
364
1.10
0.20
4.9
4.0
4.0
4.0
mmol/l
0.03
33
333
102
970
1.06
0.19
2.8
2.9
65.9
66.0
g/l
0.07
90
889
77
816
0.94
0.18
1.2
1.8
1.7
1.7
%
0.24
62
672
7
60
1.17
0.18
1.6
1.5
—
—
—
0
0
7
60
1.17
0.18
1.6
1.5
—
—
—
0
0
18
157
1.15
0.17
1.3
1.3
—
—
—
0
0
26
288
0.90
0.16
1.1
1.2
—
—
—
0
0
8
70
1.14
0.16
1.1
1.4
—
—
—
0
0
107
1029
1.04
0.14
3.7
3.1
319.2
241.9
ng/l
0.83
100
936
14
122
1.15
0.13
1.4
1.6
—
—
—
0
0
47
443
1.06
0.12
3.4
2.7
7.5
7.3
g/l
0.25
31
329
47
443
1.06
0.12
3.4
2.7
3.9
3.9
g/l
0.07
31
318
47
443
1.06
0.12
3.4
2.7
—
—
—
0
0
14
124
1.13
0.11
1.4
1.6
—
—
—
0
0
14
124
1.13
0.11
1.4
1.6
—
—
—
0
0
121
1175
1.03
0.11
1.2
1.3
24.1
45.0
iu/ml
1.78
32
361
5
47
1.06
0.09
2.6
1.2
—
—
—
0
0
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
7
65
1.08
0.08
2.6
2.5
—
—
—
0
0
6
71
0.84
0.07
1.0
1.2
93.3
95.7
%
—
6
66
18
194
0.93
0.07
1.4
1.3
1.2
0.8
nmol/l
1.02
12
155
7
82
0.85
0.07
1.0
1.0
—
—
—
0
0
146
1433
1.02
0.07
1.2
1.2
2.1
1.4
u/ml
0.30
29
353
9
87
1.03
0.07
1.1
1.1
—
—
—
0
0
8
93
0.86
0.06
1.8
2.0
3.4
4.7
mg/l
—
8
88
8
95
0.84
0.06
1.1
1.1
—
—
—
0
0
43
414
1.04
0.06
3.7
2.8
10.3
10.8
g/l
0.38
32
353
19
178
1.07
0.05
4.1
3.1
57.3
59.9
%
0.30
19
178
22
208
1.06
0.05
1.3
1.5
—
—
—
0
0
15
161
0.93
0.05
1.3
1.4
—
20.4
—
0
5
24
252
0.95
0.05
1.3
1.7
43.0
44.7
nmol/l
0.15
24
236
18
171
1.05
0.03
3.7
2.8
5.0
4.6
e9/l
0.24
18
171
14
148
0.95
0.02
1.1
1.2
282.6
320.1
u/ml
—
5
78
12
113
1.06
0.02
1.4
1.5
—
—
—
0
0
13
137
0.95
0.01
1.3
1.4
105.7
138.3
u/ml
—
6
22
24
233
1.03
0.01
1.5
1.8
10.4
12.3
mg/l
0.40
18
212
30
307
0.98
0.01
4.7
2.8
0.0
0.0
g/l
0.00
25
285
13
124
1.05
0.00
1.4
1.6
—
—
—
0
0
13
124
1.05
0.00
1.4
1.6
—
—
—
0
0
11
114
0.96
0.00
1.0
1.0
—
—
—
0
0
35
346
1.01
0.00
4.2
2.7
35.3
37.0
g/l
0.76
26
300
16
162
0.99
0.00
1.1
1.1
—
—
—
0
0
33
328
1.01
0.00
4.4
2.8
0.4
0.0
g/l
0.64
28
306
37
373
0.99
0.00
1.4
1.7
36.6
37.4
u/l
0.10
29
321
112
1125
1.00
0.00
1.2
1.2
6.0
15.9
u/ml
1.65
29
395
15
155
0.97
0.00
1.2
1.2
—
—
—
0
0
17
175
0.97
0.00
1.5
1.7
—
—
—
0
0
14
145
0.97
0.00
1.1
1.3
—
—
—
0
0
13
125
1.04
0.00
1.4
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
23.1
—
0
9
7
74
0.95
0.00
5.7
3.2
78.3
26.2
u/ml
—
7
74
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
0.00
4.0
2.6
0.3
0.2
e9/l
—
5
50
0
6
0.00
0.00
0.0
1.5
—
935.7
—
0
6
7
71
0.99
0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
0.00
1.0
1.6
—
10.4
u/l
—
0
30
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
7
75
0.93
0.00
1.6
1.5
—
—
—
0
0
5
57
0.88
0.00
4.0
2.5
816.8
586.6
e6/l
—
5
50
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
7
70
1.00
0.00
1.1
1.1
2.3
2.0
mmol/l
—
7
64
5
54
0.93
0.00
1.4
2.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
2.3
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
7
70
1.00
0.00
1.0
1.2
—
—
—
0
0
6
68
0.88
0.00
10.8
3.5
—
—
—
0
0
7
75
0.93
0.00
1.6
1.5
—
—
—
0
0
6
66
0.91
0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BLADDER – Carcinoma in situ, bladder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).